Good afternoon, everyone. Joining me on our call today to discuss the company’s third quarter 2024 results are Andrew Toy, Clover Health’s Chief Executive Officer; and Peter Kuipers, the company’s ...

Inc. (TSX: ACB) reported strong results in its fiscal Q2 2025 earnings, posting a 29% year-over-year increase in total revenue, reaching $81.1 million compared to $63.1 million in ...

Q4 2024 Earnings Call Transcript November 4, 2024 Sanmina Corporation beats earnings expectations. Reported EPS is $1.43, ...

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...

Quarter Results Semperit increases profitability in Q1–3 and confirms outlook for 2024 07.11.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement.

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

Q3 2024 Earnings Call Transcript November 5, 2024 Operator: Greetings and welcome to Gladstone Commercial Corporation Third ...

Q1 2025 Earnings Conference Call November 6, 2024 9:30 AM ETCompany ParticipantsMichael Pici - Vice President of ...

Ramp details how to write an expense policy, shares some best practices to keep in mind, and explains how automation tools ...

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a ...